Healthcare & Medical-related Industry Win the Most Strategic Financing In October

According to HSMAP statistics, the largest financing case for China’s healthcare industry in October was Alibaba’s investment in Meinian Onehealth Healthcare, with a total financing amount of RMB 7.25 billion, and the second highest is Taimei Tech’s E+ financing, amounting to RMB 2.275 billion. As for Fountain Medical, it wins the third place for its round D financing.

The accumulated financing amount for the whole month reached RMB 10.953 billion RMB, of which 15 cases were RMB 100 million. In terms of financing rounds, the ratio of strategic financing was up to 50%. In general, venture capital institutions are still very enthusiastic about the healthcare sector.

The investment preference industry is medical equipment, but in term of the investmenr scale, the largest amount money pours in the medical services, reaching RMB 8.062 billion RMB, accounting for 70% of the financing scale of the month. It is worth noting that the financing of the Meinian Onehealth Healthcare has already accounted for nearly 90%. There are also medicines, smart medical care and industrial services on the investment list. The investment area is concentrated in Beijing, Shanghai and other places. Beijing is mainly in the field of medical devices, and Shanghai is mainly in the field of medical services.

Source: https://www.hsmap.com/index

10月健康醫療大盤點 戰略融資占比最高

根據火石創造統計，10月國內醫療健康產業最大融資案非阿裡投資美年健康莫屬，總融資金額高達72.5億元，排名第二的是太美醫療的E+融資，金額為22.75億元，第三名則是方恩醫藥的D輪融資案。

累計全月的融資金額達109.53億元，其中億元級融資有15件，以融資輪次來說，戰略融資的比率是最高超過5成；總的來看，風投機構對於醫療健康領域的熱度還是很足的。

從行業領域來看，投資偏好的行業是醫療器械，但從融資規模來看卻是醫療服務的金額最大，達80.62億元，已經占了當月融資規模的7成。值得注意的是，美年健康的融資案一筆就已經補了將近9成的水平。另外榜上有名的還有藥品、智慧醫療以及產業服務等，至於融資的企業地區則集中於北京、上海等地，但北京主要的領域是醫療器械，上海則是以醫療服務為大宗。

資料來源：https://www.hsmap.com/index